1. Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13(1):1–10
2. Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound. 2013. Available from: https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf.
3. National Institute for Clinical Excellence (NICE). Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. 2015. Available from: https://www.nice.org.uk/guidance/ng5.
4. Task Force on Medicines Partnership and The National Collaborative Medicines Management Services Programme, Room for review. A guide to medication review: the agenda for patients, practitioners and managers -, L.M. Partnership, Editor. 2002.
5. D Petty, Rayner T, Zermanksy A, Alldred D. Medication review by pharmacists—the evidence still suggests benefit. Pharm J. 2005;274(7350):618–9